Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Actelion Ltd    ATLN   CH0010532478

Delayed Quote. Delayed  - 01/17 05:30:55 pm
229 CHF   -0.69%
01/06 J&J, Actelion approach Swiss takeover board over deal structure -..
2016 EXCLUSIVE - J&J : sources
2016DJWHAT'S NEWS : Business & Finance -- WSJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Actelion Ltd
Develops, produces and markets pharmaceutical drugs

Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical drugs.

It is a biopharmaceutical company, which focuses on the drug discovery, development, registration, production and commercialization of innovative drugs for diseases with significant unmet medical needs.

Its portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.

It has treatments for specialist diseases, including Type 1 Gaucher disease, Niemann-Pick type C disease, digital ulcers in patients suffering from systemic sclerosis and mycosis fungoides in patients with cutaneous T-cell lymphoma.

The company products include Tracleer (bosentan), Zavesca (miglustat), Ventavis (iloprost), Veletri (epoprostenol for injection), Valchlor and Opsumit (macitentan).

The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Mueller, and Thomas Widmann on December 17, 1997 and is headquartered in Allschwil, Switzerland.
Sales per Businesses
20142015Delta
CHF (in Million)%CHF (in Million)%
Drugs1,958100%2,045100% +4.45%
Sales per Regions
20142015Delta
CHF (in Million)%CHF (in Million)%
United States879.2444.9%1,02650.1% +16.64%
Europe687.8235.1%633.2031% -7.94%
Other360.5218.4%167.868.2% -53.44%
Switzerland30.301.5%28.391.4% -6.32%
Japan--190.069.3%-
Managers
NameAgeSinceTitle
Jean-Paul Clozel621997Chief Executive Officer & Executive Director
Jean-Pierre Garnier692011Chairman
Otto Schwarz622008Chief Operating Officer & Executive Vice President
André C. Muller, MBA542013Chief Financial Officer & Executive Vice President
Martine Clozel, MD621997Chief Scientific Officer & Senior Vice President
Michael Jacobi, PhD642009Independent Non-Executive Director
Jean Pierre Malo CFA, MBA632004Independent Non-Executive Director
Juhani Anttila63-Independent Non-Executive Director
Robert J. Bertolini, CPA54-Independent Non-Executive Director
Peter Gruss, PhD682012Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 107,761,427 94,383,714 87.6% 4,103,000 3.8% 87.6%
Shareholders
NameEquities%
Rudolf Maag, MBA 5,467,305 5.07%
Jean-Paul Clozel 5,418,507 5.03%
Actelion Ltd. 3,257,940 3.02%
UBS AG (Investment Management) 2,321,346 2.15%
The Vanguard Group, Inc. 1,897,845 1.76%
Bellevue Asset Management AG 1,704,474 1.58%
Artisan Partners LP 1,576,217 1.46%
Norges Bank Investment Management 1,502,982 1.39%
Wellington Management Co. LLP 1,419,926 1.32%
Credit Suisse AG 1,390,167 1.29%
Holdings
NameEquities%Valuation
Actelion Ltd (ATLN) 3,257,9403.02%706,819,270 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ACTELION LTD4.90%24 663
AMGEN, INC.6.78%116 141
GILEAD SCIENCES, INC.2.04%96 267
CELGENE CORPORATION1.49%91 071
REGENERON PHARMACEUTIC..0.29%38 830
VERTEX PHARMACEUTICALS..12.90%20 629
GENMAB A/S9.63%10 919
TESARO INC16.31%8 353
EXELIXIS, INC.24.14%5 302
ARIAD PHARMACEUTICALS,..90.43%4 601
HUALAN BIOLOGICAL ENGI..--.--%4 503
TONGHUA DONGBAO PHARMA..-6.98%4 210
NEUROCRINE BIOSCIENCES..9.17%3 670
PEPTIDREAM INC-0.49%3 058
ULTRAGENYX PHARMACEUTI..3.84%2 983
CHINA BIOLOGIC PRODUCT..1.46%2 960
BIOCON LTD5.28%2 934
INTERCEPT PHARMACEUTIC..5.26%2 837
BLUEBIRD BIO INC8.18%2 709
KITE PHARMA INC10.26%2 466
BEIJING SL PHARMACEUTI..--.--%2 461
Sector Bio Therapeutic Drugs
Actelion Ltd : Connections
16 Gewerbestrasse
CH-4123 Allschwil, Basel-Landschaft
Switzerland

Phone : +41 61 565 65 65
Fax : +41 61 565 65 00
Internet : http://www.actelion.com
Markets and indexes
- SIX Swiss Exchange
- Main Standard
- SMI /
Stock Exchange Codes
- ISIN Code :  CH0010532478
- Bloomberg Code :  ATLN:VX
- Reuters Code :  ATLN.VX
- Datastream Code :  S:ATLN
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem